Search for stock quotes, financial statistics and more
iA Capital Markets analyst Chelsea Stellick likes the progress being made by clinical-stage biopharm... Read More
Paradigm Capital delivered a healthcare sector update on Wednesday on drug developer NervGen Pharma ... Read More
Even with a shake-up at the helm, it’s still full steam ahead for Canadian biopharmaceutical compa... Read More
The Healthcare space has taken it on the chin this year, as stocks across the board are down by well... Read More
The stock just got a big boost from new clinical results, and that bodes well for fans of NervGen Ph... Read More
Share
Tweet
pin
Share